Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Allergy Immunotherapies (Allergy Immunotherapy) Market by Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy), By Application (Allergic Rhinitis, Allergic Asthma, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Allergy Immunotherapies (Allergy Immunotherapy) Market by Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy), By Application (Allergic Rhinitis, Allergic Asthma, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 131640 3300 Pharma & Healthcare 377 243 Pages 4.8 (44)

Market Overview:

The global allergy immunotherapies market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of allergic diseases, increasing awareness about allergy immunotherapy, and technological advancements in the field of allergy immunotherapy. The subcutaneous immunotherapy segment is expected to dominate the global allergy immunotherapies market during the forecast period. This segment is expected to grow at a CAGR of 7.8% from 2018 to 2030.

Global Allergy Immunotherapies (Allergy Immunotherapy) Industry Outlook

Product Definition:

Allergy immunotherapy, also known as desensitization or therapy, is a medical treatment for allergies. It involves exposing people to small amounts of allergens so that their immune system becomes less sensitive to them. This can be done with injections (allergy shots), tablets, or drops under the tongue.

Subcutaneous Immunotherapy:

Subcutaneous immunotherapy (SCIT) is a form of allergy immunotherapy, which involves the injection of allergens under the skin. This treatment is usually done in patients who are not able to receive vaccines or medicines for treating allergies.

According to National Institute of Health (NIH), subcutaneous immunotherapy has been used on a large scale since the early 1970s and has proven effective in both children.

Sublingual Immunotherapy:

Sublingual immunotherapy is a drug delivery method which involves the active ingredient to be administered in the form of a tablet or liquid, and then absorbed by the body through mouth. The drug is then transported to blood vessels in the lungs where it triggers an immune response, leading to allergy symptoms reduction.

Application Insights:

The allergic rhinitis segment dominated the global market in 2017. The application of subcutaneous immunotherapy for the treatment of allergic rhinitis is well established and there are several products available in the market. However, due to lack of awareness regarding this therapy among physicians and patients, its adoption is low in some regions such as Asia Pacific.

On the other hand, other applications include food allergy & anaphylaxis which accounts for a smaller share as compared to allergic rhinitis or asthma. This can be attributed to underdiagnosis and undertreatment of these conditions that have resulted in high unmet needs according to various studies conducted over past few years. For instance, according to a study published by Allergy UK on October 2016, approximately 40%of U.

Regional Analysis:

North America dominated the global market in 2017. This can be attributed to the presence of key players, such as Merck & Co., Inc.; F. Hoffmann-La Roche AG; and Allergan PLC in this region. Moreover, increasing prevalence of allergic disorders is also one of the major factors responsible for regional growth. According to an article published by NCBI, around 6 million people suffer from food allergy in U.S., out of which only 0-25% have been diagnosed [ ]. Thus, a large unmet clinical need exists for allergen immunotherapy treatment among patients with suspected food allergies [].

Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising disposable income and improving healthcare infrastructure especially in emerging countries like China and India ( ). Furthermore, growing awareness about various allergy treatments will propel market demand during the forecast period ( ).

Growth Factors:

  • Increasing prevalence of allergic diseases: The global prevalence of allergic diseases is increasing at an alarming rate. This is mainly due to the changing lifestyles and environmental factors. Allergy Immunotherapy offers a potential solution to this problem and is expected to grow at a rapid pace in the coming years.
  • Growing awareness about Allergy Immunotherapy: There is growing awareness about the benefits of Allergy Immunotherapy among both patients and healthcare professionals. This is helping to drive demand for these therapies worldwide.
  • Technological advancements: The field of allergy immunotherapy is constantly evolving with new technologies being developed all the time. This has helped to improve the efficacy and safety profile of these therapies, thus driving their growth globally.

Scope Of The Report

Report Attributes

Report Details

Report Title

Allergy Immunotherapies (Allergy Immunotherapy) Market Research Report

By Type

Subcutaneous Immunotherapy, Sublingual Immunotherapy

By Application

Allergic Rhinitis, Allergic Asthma, Other

By Companies

ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, WOLW Pharma, Holister Stier, Leti

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Allergy Immunotherapies (Allergy Immunotherapy) Market Report Segments:

The global Allergy Immunotherapies (Allergy Immunotherapy) market is segmented on the basis of:


Subcutaneous Immunotherapy, Sublingual Immunotherapy

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Allergic Rhinitis, Allergic Asthma, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. ALK-Abello
  2. Stallergenes Greer
  3. Merck
  4. Allergy Therapeutics
  5. HAL
  6. WOLW Pharma
  7. Holister Stier
  8. Leti

Global Allergy Immunotherapies (Allergy Immunotherapy) Market Overview

Highlights of The Allergy Immunotherapies (Allergy Immunotherapy) Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Subcutaneous Immunotherapy
    2. Sublingual Immunotherapy
  1. By Application:

    1. Allergic Rhinitis
    2. Allergic Asthma
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Allergy Immunotherapies (Allergy Immunotherapy) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Allergy Immunotherapies (Allergy Immunotherapy) Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

Allergy immunotherapy is a type of treatment that helps people with allergies control their symptoms. Allergy immunotherapy involves using medications to help the body’s immune system fight allergens. This can help reduce the number and severity of allergy symptoms.

Some of the key players operating in the allergy immunotherapies (allergy immunotherapy) market are ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, WOLW Pharma, Holister Stier, Leti.

The allergy immunotherapies (allergy immunotherapy) market is expected to register a CAGR of 7.5%.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Allergy Immunotherapies (Allergy Immunotherapy) Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Allergy Immunotherapies (Allergy Immunotherapy) Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Allergy Immunotherapies (Allergy Immunotherapy) Market - Supply Chain
   4.5. Global Allergy Immunotherapies (Allergy Immunotherapy) Market Forecast
      4.5.1. Allergy Immunotherapies (Allergy Immunotherapy) Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Allergy Immunotherapies (Allergy Immunotherapy) Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Allergy Immunotherapies (Allergy Immunotherapy) Market Absolute $ Opportunity

5. Global Allergy Immunotherapies (Allergy Immunotherapy) Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Type
      5.3.1. Subcutaneous Immunotherapy
      5.3.2. Sublingual Immunotherapy
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Allergy Immunotherapies (Allergy Immunotherapy) Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Application
      6.3.1. Allergic Rhinitis
      6.3.2. Allergic Asthma
      6.3.3. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Allergy Immunotherapies (Allergy Immunotherapy) Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Allergy Immunotherapies (Allergy Immunotherapy) Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Allergy Immunotherapies (Allergy Immunotherapy) Demand Share Forecast, 2019-2029

9. North America Allergy Immunotherapies (Allergy Immunotherapy) Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Application
      9.4.1. Allergic Rhinitis
      9.4.2. Allergic Asthma
      9.4.3. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Type
      9.7.1. Subcutaneous Immunotherapy
      9.7.2. Sublingual Immunotherapy
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Allergy Immunotherapies (Allergy Immunotherapy) Demand Share Forecast, 2019-2029

10. Latin America Allergy Immunotherapies (Allergy Immunotherapy) Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Application
      10.4.1. Allergic Rhinitis
      10.4.2. Allergic Asthma
      10.4.3. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Type
      10.7.1. Subcutaneous Immunotherapy
      10.7.2. Sublingual Immunotherapy
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Allergy Immunotherapies (Allergy Immunotherapy) Demand Share Forecast, 2019-2029

11. Europe Allergy Immunotherapies (Allergy Immunotherapy) Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Application
      11.4.1. Allergic Rhinitis
      11.4.2. Allergic Asthma
      11.4.3. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Allergy Immunotherapie (Allergy Immunotherapy) Market Size and Volume Forecast by Type
      11.7.1. Subcutaneous Immunotherapy
      11.7.2. Sublingual Immunotherapy
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Allergy Immunotherapies (Allergy Immunotherapy) Demand Share, 2019-2029

12. Asia Pacific Allergy Immunotherapies (Allergy Immunotherapy) Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Application
      12.4.1. Allergic Rhinitis
      12.4.2. Allergic Asthma
      12.4.3. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Type
      12.7.1. Subcutaneous Immunotherapy
      12.7.2. Sublingual Immunotherapy
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Allergy Immunotherapies (Allergy Immunotherapy) Demand Share, 2019-2029

13. Middle East & Africa Allergy Immunotherapies (Allergy Immunotherapy) Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Application
      13.4.1. Allergic Rhinitis
      13.4.2. Allergic Asthma
      13.4.3. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Allergy Immunotherapies (Allergy Immunotherapy) Market Size and Volume Forecast by Type
      13.7.1. Subcutaneous Immunotherapy
      13.7.2. Sublingual Immunotherapy
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Allergy Immunotherapies (Allergy Immunotherapy) Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Allergy Immunotherapies (Allergy Immunotherapy) Market: Market Share Analysis
   14.2. Allergy Immunotherapies (Allergy Immunotherapy) Distributors and Customers
   14.3. Allergy Immunotherapies (Allergy Immunotherapy) Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. ALK-Abello Overview Financials Developments Strategic Outlook
      14.4.2. Stallergenes Greer Overview Financials Developments Strategic Outlook
      14.4.3. Merck Overview Financials Developments Strategic Outlook
      14.4.4. Allergy Therapeutics Overview Financials Developments Strategic Outlook
      14.4.5. HAL Overview Financials Developments Strategic Outlook
      14.4.6. WOLW Pharma Overview Financials Developments Strategic Outlook
      14.4.7. Holister Stier Overview Financials Developments Strategic Outlook
      14.4.8. Leti Overview Financials Developments Strategic Outlook
      14.4.9. COMPANY9 Overview Financials Developments Strategic Outlook
      14.4.10. COMPANY 10 Overview Financials Developments Strategic Outlook
      14.4.11. COMPANY 11 Overview Financials Developments Strategic Outlook
      14.4.12. COMPANY 12 Overview Financials Developments Strategic Outlook
      14.4.13. COMPANY 13 Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us